JSR

Merck Acquires Chromatography Business from JSR Life Sciences

Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.

News

Styron Buys German S-SBR Capacity From Japanese Partner

Top-Feature

Concept Heidelberg

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

CHEManager International c/o Wiley-VCH GmbH

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Nova-Institut GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Hamilton Bonaduz AG

Optimize Your Process with Smart Oxygen Sensors for Inertization and Blanketing Applications

CHEManager International c/o Wiley-VCH GmbH

20 Years of CHEManager International

Brenntag SE

Brenntag Downsizes Management Board, Retains Both Divisions

Free Expert Insights

Advancements in Bispecific Antibody Development

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Merck KGaA

JSR

Merck Acquires Chromatography Business from JSR Life Sciences

JSR Life Sciences Acquires Selexis

JSR Life Sciences Expands US Biopharma Plants

Japanese Firms Integrate ABS Resins Businesses